US Patent Issued to The Penn State Research Foundation on Nov. 11 for "Massively parallel COVID-19 diagnostic assay for simultaneous testing of 19200 patient samples" (Pennsylvania Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,102, issued on Nov. 11, was assigned to The Penn State Research Foundation (University Park, Pa.).

"Massively parallel COVID-19 diagnostic assay for simultaneous testing of 19200 patient samples" was invented by Howard Salis (University Park, Pa.), Alexander Reis (University Park, Pa.) and Ayaan Hossain (University Park, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and systems for the massively-parallel detection of pathogens, such as SARS-CoV-2 virus, in a set of multiple samples via PCR test. Various implementations may provide for barcode/primer sequences that are designed to allow for a large number ...